Expanded Distribution For COVID Vaccines Will Boost Options – And Logistical Complications
Executive Summary
Operation Warp Speed officials eye the Moderna vaccine and upcoming one-shot Janssen product to widen the immunization campaign’s reach, but more products also could bring more problems.
You may also be interested in...
Biden Wants To Release More COVID-19 Vaccine, But Also Maintain Strategic Reserve
Rather than holding half of all vaccines produced to ensure administration of the second dose, only a portion would be held to cover for manufacturing or other problems.
FY 2021 Appropriations Provides FDA Healthy Boost – Plus More COVID-19 Funds
Budget authority increase for medical product safety is coupled with additional funds for coronavirus countermeasure development and advanced manufacturing.
J&J Exec On COVID-19 Vaccine: Moving At High Speed But No Safety Compromises
J&J executive emphasizes that fast-tracked development of COVID-19 vaccines does not come with any corners cut around safety. Indian partner Biological E also outlines the complexities in manufacturing and believes that the candidates from J&J, AstraZeneca and others will be more suitable in profile and price terms to contain the pandemic globally.